UCB
This role involves contributing to the development and optimization of viral vector manufacturing processes using advanced cell culture technologies and bioreactor systems. The position requires designing and executing experimental studies to improve process performance, scalability, and product quality for cell and gene therapies. Candidates will apply digital technologies and data analytics to support process innovation while collaborating with multidisciplinary teams to translate scientific innovations into robust manufacturing solutions.
Headquarters
Brussels, Brussels, Belgium
Company Size
5001-10000 employees
Founded
1928
UCB a global biopharmaceutical leader focuses on creating valuable solutions that improve the lives of people living with neurological and autoimmune conditions
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for UCB.
UCB didn’t post a salary, so this is our estimate from similar listings.
Scientist I/II, Viral Vector Process Development
Asimov
Global Viral Vector MSAT Lead
Legend Biotech
BioProcess Engineer II, Upstream
ImmunityBio
Clinical Process Development & Manufacturing Professional I (Manufacturing Assistant/Associate)
Oracle
Exec Director, Viral Vector Process Development
Gilead Sciences
Senior Scientist Vector Engineering
AstraZeneca